|
US347A
(en)
|
|
1837-08-08 |
|
dixon |
|
US7741A
(en)
|
|
1850-10-29 |
|
Cak-cottpling |
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6054472A
(en)
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
|
ATE346085T1
(de)
|
1996-12-06 |
2006-12-15 |
Vertex Pharma |
Inhibitoren des interleukin-1-beta konvertierenden enzyms
|
|
AP1498A
(en)
|
1999-03-19 |
2005-11-21 |
Vertex Pharma |
Inhibitors of impdh enzyme.
|
|
US6448281B1
(en)
|
2000-07-06 |
2002-09-10 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
|
EP1256628A3
(en)
|
2001-05-10 |
2003-03-19 |
Agouron Pharmaceuticals, Inc. |
Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
|
|
US6881741B2
(en)
|
2001-06-11 |
2005-04-19 |
Virochem Pharma Inc. |
Compounds and methods for the treatment or prevention of Flavivirus infections
|
|
WO2002100846A1
(en)
|
2001-06-11 |
2002-12-19 |
Shire Biochem Inc. |
Compounds and methods for the treatment or prevention of flavivirus infections
|
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
|
CA2448737C
(en)
|
2001-07-20 |
2010-06-01 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
|
ES2289161T3
(es)
|
2001-11-02 |
2008-02-01 |
Glaxo Group Limited |
Derivados de 4-(heteroaril de 6 miembros)-acil pirrolidina como inhibidores de hcv.
|
|
EA009943B1
(ru)
|
2002-11-01 |
2008-04-28 |
Вирофарма Инкорпорейтед |
Соединения бензофурана, композиции и способы лечения и профилактики инфекций, вызванных вирусом гепатита с, и связанных с ним заболеваний
|
|
DK1625154T3
(da)
*
|
2003-05-09 |
2014-02-24 |
Boehringer Ingelheim Int |
Hepatitis c virus ns5b-polymeraseinhibitor-bindende lomme
|
|
JP4902361B2
(ja)
|
2004-01-30 |
2012-03-21 |
メディヴィル・アクチエボラーグ |
Ｈｃｖｎｓ−３セリンプロテアーゼインヒビター
|
|
EP1746888A2
(en)
|
2004-05-13 |
2007-01-31 |
Viropharma Incorporated |
Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
|
|
WO2006019831A1
(en)
|
2004-07-14 |
2006-02-23 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7772271B2
(en)
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7868037B2
(en)
|
2004-07-14 |
2011-01-11 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US8076365B2
(en)
*
|
2005-08-12 |
2011-12-13 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
US20070265335A1
(en)
|
2005-11-10 |
2007-11-15 |
Wyeth |
Polymorphs of 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsufonyl)amino]-n-methyl-1-benzofuran-3-carboxamide and methods of making the same
|
|
KR20090012345A
(ko)
|
2006-05-30 |
2009-02-03 |
애로우 쎄라퓨틱스 리미티드 |
바이페닐 유도체, 및 ｃ형 간염 치료에 있어서의 이들의 용도
|
|
GB0614940D0
(en)
|
2006-07-27 |
2006-09-06 |
Arternis Intelligent Power Ltd |
Vehicle traction and stability control system employing control of fluid quanta
|
|
US7759495B2
(en)
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8303944B2
(en)
|
2006-08-11 |
2012-11-06 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7659270B2
(en)
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20080275032A1
(en)
|
2006-12-29 |
2008-11-06 |
Yuefen Zhou |
Pyridazinone compounds
|
|
MX2009008439A
(es)
|
2007-02-12 |
2009-08-13 |
Intermune Inc |
Nuevos inhibidores de la replicacion del virus de hepatitis c.
|
|
GB0707000D0
(en)
*
|
2007-04-12 |
2007-05-30 |
Istituto Di Ricerche D Biolog |
Antiviral agents
|
|
JP5793726B2
(ja)
|
2007-05-23 |
2015-10-14 |
ブイジーエックスアイ，インコーポレイティド |
高濃度の生物学的に活性な分子を含む組成物とその製造方法
|
|
US7728027B2
(en)
|
2007-08-08 |
2010-06-01 |
Bristol-Myers Squibb Company |
Process for synthesizing compounds useful for treating hepatitis C
|
|
CA2695989A1
(en)
|
2007-08-10 |
2009-02-19 |
Glaxosmithkline Llc |
Certain nitrogen containing bicyclic chemical entities for treating viral infections
|
|
EP2408761B1
(en)
|
2007-08-29 |
2014-01-01 |
Merck Sharp & Dohme Corp. |
Substituted indole derivatives and methods of use thereof
|
|
KR100903411B1
(ko)
|
2007-10-16 |
2009-06-18 |
(주)다산알앤디 |
자동속도조절 러닝머신 및 그 제어모듈
|
|
US8377928B2
(en)
|
2007-11-16 |
2013-02-19 |
Merck Sharp & Dohme Corp. |
3-aminosulfonyl substituted indole derivatives and methods of use thereof
|
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
ATE539070T1
(de)
|
2008-02-14 |
2012-01-15 |
Hoffmann La Roche |
Heterozyklische antivirale verbindungen
|
|
WO2009137493A1
(en)
|
2008-05-05 |
2009-11-12 |
Wyeth |
2-substituted benzofuran compounds to treat infection with hepatitis c virus
|
|
WO2009137500A1
(en)
|
2008-05-05 |
2009-11-12 |
Wyeth |
6-substituted benzofuran compounds to treat infection with hepatitis c virus
|
|
CN101635673B
(zh)
|
2008-07-25 |
2012-01-25 |
华为技术有限公司 |
预订路径的方法、系统及路径计算客户、路径计算单元
|
|
US7906655B2
(en)
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8198449B2
(en)
|
2008-09-11 |
2012-06-12 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US8293909B2
(en)
|
2008-09-11 |
2012-10-23 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US8048887B2
(en)
|
2008-09-11 |
2011-11-01 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US7994171B2
(en)
|
2008-09-11 |
2011-08-09 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
JP2010092550A
(ja)
|
2008-10-09 |
2010-04-22 |
Hitachi Global Storage Technologies Netherlands Bv |
磁気記録ヘッド、その製造方法及び磁気記録再生装置
|
|
US8729077B2
(en)
|
2008-11-28 |
2014-05-20 |
Glaxosmithkline Llc |
Anti-viral compounds, compositions, and methods of use
|
|
CA2750577A1
(en)
|
2008-12-03 |
2010-06-10 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
US8546405B2
(en)
|
2008-12-23 |
2013-10-01 |
Abbott Laboratories |
Anti-viral compounds
|
|
WO2010096462A1
(en)
|
2009-02-17 |
2010-08-26 |
Enanta Pharmaceuticals, Inc |
Linked diimidazole derivatives
|
|
TWI438200B
(zh)
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
Ｃ型肝炎病毒抑制劑
|
|
WO2010094977A1
(en)
|
2009-02-23 |
2010-08-26 |
Arrow Therapeutics Limited |
Novel biphenyl compounds useful for the treatment of hepatitis c
|
|
CN104856991A
(zh)
|
2009-02-27 |
2015-08-26 |
西佳技术公司 |
用于治疗和预防登革热病毒感染的噻吩并吡啶衍生物
|
|
CA2761279A1
(en)
|
2009-05-20 |
2010-11-25 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
AU2010341537A1
(en)
*
|
2009-12-22 |
2012-08-09 |
Merck Sharp & Dohme Corp. |
Fused Tricyclic Compounds and methods of use thereof for the treatment of viral diseases
|
|
WO2011103063A1
(en)
|
2010-02-19 |
2011-08-25 |
Glaxo Group Limited |
Therapeutic compounds
|
|
TW201136919A
(en)
|
2010-03-02 |
2011-11-01 |
Merck Sharp & Amp Dohme Corp |
Inhibitors of hepatitis C virus NS5B polymerase
|
|
WO2011106929A1
(en)
|
2010-03-02 |
2011-09-09 |
Merck Sharp & Dohme Corp. |
Inhibitors of hepatitis c virus ns5b polymerase
|
|
EP2545060B1
(en)
*
|
2010-03-09 |
2015-11-25 |
Merck Sharp & Dohme Corp. |
Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
|
|
WO2011112186A1
(en)
|
2010-03-10 |
2011-09-15 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis c
|
|
US8354410B2
(en)
|
2010-03-11 |
2013-01-15 |
Bristol-Meyers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
CN102906080A
(zh)
|
2010-03-11 |
2013-01-30 |
百时美施贵宝公司 |
治疗丙型肝炎的化合物
|
|
AR082453A1
(es)
*
|
2010-04-21 |
2012-12-12 |
Novartis Ag |
Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos
|
|
SG189985A1
(en)
|
2010-10-26 |
2013-06-28 |
Presidio Pharmaceuticals Inc |
Inhibitors of hepatitis c virus
|
|
WO2013163466A1
(en)
*
|
2012-04-25 |
2013-10-31 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hepatitis c virus
|